Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion : A Case Report

Joint Authors

Spicka, Ivan
Trneny, Marek
Klener, Pavel
Klanova, Magdalena
Straub, Jan

Source

Case Reports in Immunology

Issue

Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-3, 3 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2012-10-11

Country of Publication

Egypt

No. of Pages

3

Main Subjects

Biology

Abstract EN

Myelomatous pleural effusion (MPE) is an extremely rare manifestation of multiple myeloma (MM).

We present a case of MPE in a patient with IgG-κ MM treated with intrapleural bortezomib with systemic bortezomib-based therapy.

Although we observed good local response, the patient succumbed due to systemic myeloma progression.

American Psychological Association (APA)

Klanova, Magdalena& Klener, Pavel& Trneny, Marek& Straub, Jan& Spicka, Ivan. 2012. Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion : A Case Report. Case Reports in Immunology،Vol. 2012, no. 2012, pp.1-3.
https://search.emarefa.net/detail/BIM-513045

Modern Language Association (MLA)

Klanova, Magdalena…[et al.]. Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion : A Case Report. Case Reports in Immunology No. 2012 (2012), pp.1-3.
https://search.emarefa.net/detail/BIM-513045

American Medical Association (AMA)

Klanova, Magdalena& Klener, Pavel& Trneny, Marek& Straub, Jan& Spicka, Ivan. Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion : A Case Report. Case Reports in Immunology. 2012. Vol. 2012, no. 2012, pp.1-3.
https://search.emarefa.net/detail/BIM-513045

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-513045